Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Waagstein

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
European Heart Journal|December 1, 1995
Adrenergic beta-blocking agents in congestive heart failure due to idiopathic dilated cardiomyopathyF Waagstein
Heart and Vessels. Supplement|January 1, 1991
Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathiesF Waagstein
Cardiology|January 1, 1993
Beta blockers in heart failureF Waagstein
Ernst Schering Research Foundation Workshop|December 7, 2005
Invited for debate: is there a virus-specific matrix destruction in the course of disease in dilated cardiomyopathy?F Waagstein
The American Journal of Cardiology|December 31, 1997
Efficacy of beta blockers in idiopathic dilated cardiomyopathy and ischemic cardiomyopathyF Waagstein
Herz|June 1, 1985
Pharmacologic treatment of dilated cardiomyopathy with special reference to the role of beta-blockersF Waagstein
Nordisk Medicin|April 9, 1970
[Procaine-induced lupus erythematosus]F Waagstein
Current Opinion in Cardiology|May 1, 1995
The role of beta-blockers in dilated cardiomyopathyF Waagstein
Lakartidningen|November 22, 1978
[Beta-blocking and beta-stimulation in left ventricular failure]F Waagstein
American Heart Journal|September 1, 1993
Spectrum and outcome of congestive heart failure in a hospitalized populationB Andersson, F Waagstein
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
European Heart Journal|December 1, 1995
Adrenergic beta-blocking agents in congestive heart failure due to idiopathic dilated cardiomyopathyF Waagstein
Heart and Vessels. Supplement|January 1, 1991
Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathiesF Waagstein
Cardiology|January 1, 1993
Beta blockers in heart failureF Waagstein
Ernst Schering Research Foundation Workshop|December 7, 2005
Invited for debate: is there a virus-specific matrix destruction in the course of disease in dilated cardiomyopathy?F Waagstein
The American Journal of Cardiology|December 31, 1997
Efficacy of beta blockers in idiopathic dilated cardiomyopathy and ischemic cardiomyopathyF Waagstein
Herz|June 1, 1985
Pharmacologic treatment of dilated cardiomyopathy with special reference to the role of beta-blockersF Waagstein
Nordisk Medicin|April 9, 1970
[Procaine-induced lupus erythematosus]F Waagstein
Current Opinion in Cardiology|May 1, 1995
The role of beta-blockers in dilated cardiomyopathyF Waagstein
Lakartidningen|November 22, 1978
[Beta-blocking and beta-stimulation in left ventricular failure]F Waagstein
American Heart Journal|September 1, 1993
Spectrum and outcome of congestive heart failure in a hospitalized populationB Andersson, F Waagstein
Pageof 15